Effects of combined administration of the proteasome inhibitor lactacystin and the pesticide rotenone on striatal dopamine metabolism and cell viability in vivo and in vitro

被引：0

作者：

Konieczny, Jolanta ^{[1
]}

Lenda, Tomasz ^{[1
]}

Jantas, Danuta ^{[2
]}

Antkiewicz-Michaluk, Lucyna ^{[3
]}

Zapala, Malgorzata ^{[1
]}

Lorenc-Koci, Elzbieta ^{[1
]}

机构：

[1] Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, PL-31343 Krakow, Poland

[2] Polish Acad Sci, Inst Pharmacol, Dept Expt Neuroendocrinol, PL-31343 Krakow, Poland

[3] Polish Acad Sci, Inst Pharmacol, Dept Neurochem, PL-31343 Krakow, Poland

来源：

PHARMACOLOGICAL REPORTS | 2009年 / 61卷 / 02期

关键词：

D O I：

10.1016/S1734-1140(09)70050-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：356 / 357

页数：2

共 10 条

[1] Effects of combined administration of the proteasome inhibitor lactacystin and the pesticide rotenone on striatal dopamine metabolism and cell viability in vivo and in vitro
Jolanta Konieczny
Tomasz Lenda
Danuta Jantas
Lucyna Antkiewicz-Michaluk
Małgorzata Zapała
Elżbieta Lorenc-Koci
Pharmacological Reports, 2009, 61 : 356 - 357
[2] Effects of combined exposure to the pesticide rotenone and the proteasome inhibitor lactacystin on striatal dopamine metabolism in rats
Konieczny, J.
Lorenc-Koci, E.
Antkiewiez-Michaluk, L.
Lenda, T.
Zapala, M.
Ossowska, K.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S129 - S130
[3] Subchronic exposure to the pesticide rotenone potentiates the effect of intranigral administration of the proteasome inhibitor lactacystin on striatal dopamine metabolism in rats
Konieczny, Jolanta
Lenda, Tomasz
Antkiewicz-Michaluk, Lucyna
Zapala, Malgorzata
Lorenc-Koci, Elzbieta
PHARMACOLOGICAL REPORTS, 2008, 60 (02) : 283 - 284
[4] Celastrol potentiates striatal dopamine metabolism and increases cell death under conditions of proteasome inhibition: in vivo and in vitro studies
Tomasz Lenda
Jolanta Konieczny
Danuta Jantas
Małgorzata Zapała
Elłbieta Lorenc-Koci
Pharmacological Reports, 2009, 61 : 359 - 360
[5] Celastrol potentiates striatal dopamine metabolism and increases cell death under conditions of proteasome inhibition: in vivo and in vitro studies
Lenda, Tomasz
Konieczny, Jolanta
Jantas, Danuta
Zapala, Malgorzata
Lorenc-Koci, Elzbieta
PHARMACOLOGICAL REPORTS, 2009, 61 (02) : 359 - 360
[6] The proteasome inhibitor lactacystin exerts its therapeutic effects on glioma via apoptosis: An in vitro and in vivo study
Wang, Haifeng
Zhang, Shuyan
Zhong, Jiateng
Zhang, Jizhou
Luo, Yinan
Ge, Pengfei
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (01) : 72 - 81
[7] Effects of intracerebral administration of the selective proteasome inhibitor lactacystin on dopamine metabolism in, the striatum and on the number of tyrosine hydroxylase immunoreactive neurons in the substantia nigra pars compacta
Lorenc-Koci, Elzbieta
Antkiewicz-Michaluk, Lucyna
Lenda, Tomasz
Kuter, Katarzyna
Zapala, Malgorzata
Konieczny, Jolanta
PHARMACOLOGICAL REPORTS, 2008, 60 (02) : 285 - 285
[8] Systemic administration of 1,2,3,4-tetrahydroisoquinoline prevents the loss of striatal dopamine in rats injected intranigrally with the selective proteasome inhibitor lactacystin
Elżbieta Lorenc-Koci
Tomasz Lenda
Małgorzata Zapała
Jolanta Konieczny
Pharmacological Reports, 2009, 61 : 360 - 361
[9] Systemic administration of 1,2,3,4-tetrahydroisoquinoline prevents the loss of striatal dopamine in rats injected intranigrally with the selective proteasome inhibitor lactacystin
Lorenc-Koci, Elzbieta
Lenda, Tomasz
Zapala, Malgorzata
Konieczny, Jolanta
PHARMACOLOGICAL REPORTS, 2009, 61 (02) : 360 - 361
[10] In-vitro-effects of the combined administration of tyrosine kinase inhibitor ST1571 and ionizing radiation on a human glioblastoma cell line: Potential use as a radiosensitizer?
Holdhoff, M
le Coutre, P
Kreuzer, KA
Appelt, C
Jordan, A
Scholz, R
Na, IK
Schwarz, M
Lupberger, J
Schmidt, CA
STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 48 - 48

← 1 →